Please login to the form below

Not currently logged in
Email:
Password:

RPSGB calls for NHS to provide better access to medicines

The Royal Pharmaceutical Society of Great Britain has called for improved access to effective medicines for NHS patients

The Royal Pharmaceutical Society of Great Britain (RPSGB) has called for improved access to effective medicines for NHS patients.

Welcoming the government's decision to allow patients to top-up their NHS treatment without losing their entitlement to further services, the RPSGB has said that greater emphasis should be put on improving the access to and affordability of medicines.

"The need for top-ups should be minimised as far as possible. Top-ups should be the exception, not the rule. The emphasis of this argument must be on improving access to medicines for NHS patients," said RPSGB President Steve Churton.

"Patients also need to be better informed about the medicines available to them, through access to unbiased information, so that they can make the best possible choices about their personal treatment. However, measures should be put in place to protect vulnerable patients from misleading claims. Pharmacists will play a key role in advising patients and helping them access trustworthy sources of information in these situations."

The Department of Health (DH) published Improving Access to Medicines for NHS Patients at the beginning of November 2008. The report by Professor Mike Richards, the national clinical director for cancer outlines the key recommendations for the top-up procedure.

10th November 2008

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics